Intracranial Stenting as a Rescue Therapy in Patients with Stroke-in-Evolution
- Authors
- Seo, Woo-Keun; Oh, Kyungmi; Suh, Sang-il; Seol, Hae Young
- Issue Date
- 6월-2016
- Publisher
- ELSEVIER
- Keywords
- Brain infarct; stents; neurological deterioration; outcome
- Citation
- JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, v.25, no.6, pp.1411 - 1416
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF STROKE & CEREBROVASCULAR DISEASES
- Volume
- 25
- Number
- 6
- Start Page
- 1411
- End Page
- 1416
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/88522
- DOI
- 10.1016/j.jstrokecerebrovasdis.2016.01.054
- ISSN
- 1052-3057
- Abstract
- Background: The feasibility and efficacy of intracranial stenting were evaluated for patients with a stroke-in-evolution after the time window for thrombolysis. Methods: Patients with symptomatic intracranial steno-occlusive disease with progressive or fluctuating symptoms were treated using intracranial stenting after the time window for hyperacute thrombolysis. Results: Within the study period, we identified 10 patients (7 men, 62.5 +/- 11.3 years old) who were eligible for inclusion. The median onset-to-arrival time was 5.8 hours (range:.6-144 hours), and the median onset-to-procedure time was 33 hours (range: 8-346 hours). Only 1 patient previously received intravenous thrombolysis using alteplase. The symptomatic occlusive artery was the right middle cerebral artery, left middle cerebral artery, and basilar artery in 3, 1, and 6 patients, respectively. The median initial National Institutes of Health Stroke Scale (NIHSS) score was 4 (range: 0-6), and the median NIHSS score measured immediately before the procedure was 8 (range: 4-26). All but 1 patient underwent successful angioplasty and stenting using a Wingspan stent. Reocclusion of the stented artery occurred in 1 patient, and his neurological status deteriorated to coma. A favorable outcome (modified Rankin Scale <= 2) at 3 months was noted in 7 patients (70%). Conclusion: Intracranial stenting could be considered an alternative strategy for treating patients with medically intractable stroke-in-evolution. (C) 2016 National Stroke Association. Published by Elsevier Inc. All rights reserved.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.